Anuj Mrfr σε πρόσθεσε στο Health
2026-02-13 06:39:31 - Μετάφραση

Boost Your Post

Title

Pay Model
Pay Per Click

Pay Per View

Budget ($)

Target Location

Age Range

Gender

The "Gut-Liver Axis" Strategy: Is 2026 the Year We Treat the Intestine to Save the Liver?
A major shift in the 2026 global industry is the record-breaking focus on "PSC-IBD Combined Care." Because nearly 80% of PSC patients also suffer from Inflammatory Bowel Disease (IBD), the Primary Sclerosing Cholangitis Market has launched several trials for dual-action therapies. This year, research into COL7A1 and ABCB9 proteins has identified them as shared genetic targets for both...

0 Σχόλια 0 Μοιράστηκε 15 Views 0 Προεπισκόπηση

Παρακαλούμε συνδέσου στην Κοινότητά μας για να δηλώσεις τι σου αρέσει, να σχολιάσεις και να μοιραστείς με τους φίλους σου!

Προωθημένο